National Notifiable Diseases Surveillance System, 1 April to 30 June 2016

The National Notifiable Diseases Surveillance System collates data from Australian states and territories. These data have been published on the Department of Health website and quarterly data are published in Communicable Diseases Intelligence. This page contains data for the reporting period1 April to 30 June 2016.

Page last updated: 30 September 2016

A summary of diseases currently being reported by each jurisdiction is provided in Table 1. There were 67,081 notifications to the National Notifiable Diseases Surveillance System (NNDSS) between 1 April and 30 June 2016 (Table 2). The notification rate of diseases per 100,000 population for each state or territory is presented in Table 3.

Table 1: Reporting of notifiable diseases by jurisdiction
Disease Data received from:
Bloodborne diseases
Hepatitis (NEC) All jurisdictions
Hepatitis B (newly acquired) All jurisdictions
Hepatitis B (unspecified) All jurisdictions
Hepatitis C (newly acquired) All jurisdictions except Queensland
Hepatitis C (unspecified) All jurisdictions
Hepatitis D All jurisdictions
Gastrointestinal diseases
Botulism All jurisdictions
Campylobacteriosis All jurisdictions except New South Wales
Cryptosporidiosis All jurisdictions
Haemolytic uraemic syndrome All jurisdictions
Hepatitis A All jurisdictions
Hepatitis E All jurisdictions
Listeriosis All jurisdictions
Paratyphoid All jurisdictions
Shiga toxin/verotoxin-producing Escherichia coli All jurisdictions
Salmonellosis All jurisdictions
Shigellosis All jurisdictions
Typhoid fever All jurisdictions
Quarantinable diseases
Avian influenza in humans All jurisdictions
Cholera All jurisdictions
Middle East respiratory syndrome coronavirus All jurisdictions
Plague All jurisdictions
Rabies All jurisdictions
Severe acute respiratory syndrome All jurisdictions
Smallpox All jurisdictions
Viral haemorrhagic fever All jurisdictions
Yellow fever All jurisdictions
Sexually transmissible infections
Chlamydia All jurisdictions
Donovanosis All jurisdictions
Gonococcal infection All jurisdictions
Syphilis < 2 years duration All jurisdictions
Syphilis > 2 years or unspecified duration All jurisdictions
Syphilis - congenital All jurisdictions
Vaccine preventable diseases
Diphtheria All jurisdictions
Haemophilus influenzae type b All jurisdictions
Influenza (laboratory confirmed) All jurisdictions
Measles All jurisdictions
Mumps All jurisdictions
Pertussis All jurisdictions
Pneumococcal disease – invasive All jurisdictions
Poliovirus infection All jurisdictions
Rubella All jurisdictions
Rubella - congenital All jurisdictions
Tetanus All jurisdictions
Varicella zoster (chickenpox) All jurisdictions except New South Wales
Varicella zoster (shingles) All jurisdictions except New South Wales
Varicella zoster (unspecified) All jurisdictions except New South Wales
Vectorborne diseases
Barmah Forest virus infection All jurisdictions
Chikungunya virus infection All jurisdictions
Dengue virus infection All jurisdictions
Flavivirus infection (unspecified) All jurisdictions
Japanese encephalitis virus infection All jurisdictions
Kunjin virus infection All jurisdictions
Malaria All jurisdictions
Murray Valley encephalitis virus infection All jurisdictions
Ross River virus infection All jurisdictions
Zoonoses
Anthrax All jurisdictions
Australian bat lyssavirus infection All jurisdictions
Brucellosis All jurisdictions
Leptospirosis All jurisdictions
Lyssavirus infection (NEC) All jurisdictions
Ornithosis All jurisdictions
Q fever All jurisdictions
Tularaemia All jurisdictions
Other bacterial infections
Legionellosis All jurisdictions
Leprosy All jurisdictions
Meningococcal infection – invasive All jurisdictions
Tuberculosis All jurisdictions
NEC Not elsewhere classified.

Top of page

Table 2: Notifications of diseases received by state and territory health authorities, 1 April to 30 June 2016, by date of diagnosis*
State or territory Total 2nd quarter 2016 Total 1st quarter 2016 Total 2nd quarter 2015 Last 5 years mean 2nd quarter Ratio Year to date 2016 Last 5 years YTD mean
Disease ACT NSW NT Qld SA Tas. Vic. WA

* The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. For hepatitis B (unspecified), hepatitis C (unspecified), leprosy, syphilis (> 2 years or unspecified duration) and tuberculosis, the public health unit notification receive date was used.

† Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis. Queensland reports hepatitis C newly acquired under hepatitis   unspecified.

‡ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined or is greater than 24 months.

§ Infection with Shiga toxin/verotoxin-producing Escherichia coli.

|| Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral and throat samples, except for South Australia, which reports only cervical, urine and urethral specimens.

¶ The national case definitions for chlamydia, gonococcal and syphilis diagnoses include infections that may be acquired through a non-sexual mode (especially in children – e.g. perinatal infections, epidemic gonococcal conjunctivitis).

** Only invasive meningococcal disease is nationally notifiable. However, New South Wales and the Australian Capital Territory also report conjunctival cases.

NN Not notifiable

NEC Not elsewhere classified

Totals comprise data from all states and territories. Cumulative figures are subject to retrospective revision so there may be discrepancies between the number of new notifications and the increment in the cumulative figure from the previous period.
Bloodborne diseases
Hepatitis (NEC) 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Hepatitis B (newly acquired)† 0 2 0 13 0 0 17 9 41 41 38 41.4 1.0 83 89.8
Hepatitis B (unspecified)‡ 22 666 32 284 78 13 537 244 1,876 1,573 1,501 1,583.2 1.2 3,458 3,166.6
Hepatitis C (newly acquired)† 4 3 1 0 8 4 26 29 75 89 104 107.6 0.7 164 222.0
Hepatitis C (unspecified)‡ 48 1,081 61 703 126 52 664 327 3,062 3,018 2,452 2,456.2 1.2 6,084 4,938.0
Hepatitis D 0 4 2 1 2 0 3 0 12 15 12 13.4 0.9 27 25.8
Gastrointestinal diseases
Botulism 0 0 0 0 0 0 0 0 0 0 1 0.8 0.0 0 1.4
Campylobacteriosis 125 NN 111 1,625 608 207 1,752 759 5,187 5,876 5,006 4,031.8 1.3 11,109 8,732.4
Cryptosporidiosis 10 311 109 685 103 5 205 71 1,499 2,299 971 830.2 1.8 3,812 2,065.8
Haemolytic uraemic syndrome 0 0 0 0 0 1 0 0 1 4 4 3.6 0.3 5 9.2
Hepatitis A 0 9 0 4 2 0 6 2 23 53 28 36.2 0.6 78 102.4
Hepatitis E 0 1 0 3 0 0 0 1 5 15 6 10.4 0.5 20 23.2
Listeriosis 0 12 0 5 0 1 4 1 23 27 18 19.0 1.2 50 41.4
Paratyphoid 0 4 0 2 0 1 5 1 13 33 12 16.4 0.8 46 44.4
STEC§ 0 8 0 3 31 0 7 6 55 60 35 27.0 2.0 115 60.4
Salmonellosis 78 1,067 245 1,209 461 75 929 451 4,515 6,488 4,044 3,252.2 1.4 11,059 8,117.2
Shigellosis 2 88 40 30 11 2 154 21 348 351 244 157.2 2.2 712 379.8
Typhoid fever 0 4 0 6 1 0 6 2 19 37 29 24.8 0.8 56 79.0
Quarantinable diseases
Avian influenza in humans 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Cholera 0 0 0 0 0 0 0 0 0 0 1 2.2 0.0 0 2.6
Middle East respiratory syndrome coronavirus 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Plague 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Rabies 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Severe acute respiratory syndrome 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Smallpox 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Viral haemorrhagic fever 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Yellow fever 0 0 0 0 0 0 0 0 0 0 0 0.4 0.0 0 0.4
Sexually transmissible infections
Chlamydia||,¶ 362 6,672 663 5,794 1,418 446 1,154 3,077 19,586 18,620 16,560 20,160.0 1.0 38,238 42,224.6
Donovanosis 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.2
Gonococcal infection 39 1,818 437 938 332 23 1,751 834 6,172 5,584 4,560 3,800.2 1.6 11,782 7,669.8
Syphilis < 2 years duration 5 186 41 160 21 1 271 68 753 776 631 450.2 1.7 1,541 896.6
Syphilis > 2 years or unspecified duration‡,¶ 7 89 10 69 26 5 219 13 438 471 487 415.8 1.1 911 819.6
Syphilis – congenital 0 0 0 0 0 0 0 0 0 0 1 0.6 0.0 0 1.4
Vaccine preventable diseases
Diphtheria 0 0 0 1 0 0 0 0 1 1 0 0.8 1.3 2 1.2
Haemophilus influenzae type b 0 1 0 1 1 0 2 0 5 4 4 4.8 1.0 9 7.6
Influenza (laboratory confirmed) 71 2,633 52 2,139 492 73 1,041 767 7,268 5,772 9,757 5,661.4 1.3 13,065 8,589.0
Measles 0 2 0 2 2 3 10 0 19 37 19 33.8 0.6 56 93.8
Mumps 0 12 18 11 5 1 4 137 188 331 99 61.2 3.1 519 115.4
Pertussis 99 2,014 54 463 271 9 653 236 3,799 5,766 4,180 4,456.6 0.9 9,666 10,051.6
Pneumococcal disease – invasive 7 146 10 77 33 17 111 39 440 177 401 459.8 1.0 622 676.6
Poliovirus infection 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Rubella 0 5 0 1 0 0 3 0 9 3 4 7.4 1.2 12 16.8
Rubella – congenital 0 0 0 0 0 0 0 0 0 0 0 0.2 0.0 0 0.2
Tetanus 0 0 0 1 0 0 0 0 1 3 1 0.8 1.3 4 2.0
Varicella zoster (chickenpox) 15 NN 14 88 79 22 235 137 590 589 548 470.8 1.3 1,181 908.8
Varicella zoster (shingles) 63 NN 97 18 547 78 520 370 1,693 1,767 1,601 1,251.8 1.4 3,475 2,518.2
Varicella zoster (unspecified) 51 NN 3 1,836 41 36 1,430 369 3,766 3,786 3,272 2,567.8 1.5 7,564 5,154.6
Vectorborne diseases
Barmah Forest virus infection 0 9 1 86 0 0 0 3 99 141 187 539.0 0.2 240 1,202.0
Chikungunya virus infection 0 1 1 1 3 0 5 2 13 18 29 22.4 0.6 31 47.8
Dengue virus infection 7 122 38 135 29 15 139 179 664 729 427 398.2 1.7 1,400 986.4
Flavivirus infection (unspecified) 0 2 1 10 0 1 2 1 17 52 2 4.2 4.0 70 8.6
Japanese encephalitis virus infection 0 0 0 0 0 0 0 0 0 0 0 0.4 0.0 0 1.0
Kunjin virus infection 0 0 0 0 0 0 0 0 0 0 0 0.4 0.0 0 0.4
Malaria 1 13 2 21 3 0 19 11 70 70 48 76.4 0.9 141 174.0
Murray Valley encephalitis virus infection 0 0 0 0 0 0 0 0 0 0 1 1.6 0.0 0 3.6
Ross River virus infection 2 147 42 883 12 2 39 106 1,233 1,697 2,001 1,360.8 0.9 2,935 4,156.0
Zoonoses
Anthrax 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Australian bat lyssavirus infection 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.2
Brucellosis 0 2 0 1 0 0 0 0 3 2 7 5.2 0.6 5 11.8
Leptospirosis 0 3 0 32 0 0 0 2 37 50 17 35.4 1.0 87 81.8
Lyssavirus infection (NEC) 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.0
Ornithosis 0 1 0 0 0 0 0 0 1 2 2 11.4 0.1 3 22.4
Q fever 1 37 0 52 3 0 8 4 105 141 144 113.4 0.9 250 232.2
Tularaemia 0 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0 0.2
Other bacterial infections
Legionellosis 1 36 0 11 7 5 17 22 99 83 100 103.4 1.0 182 194.4
Leprosy 0 1 0 2 0 0 1 0 4 4 3 3.4 1.2 8 4.8
Meningococcal infection – invasive** 0 15 1 8 6 0 15 1 46 43 48 47.8 1.0 91 84.4
Tuberculosis 8 99 9 42 17 2 86 28 291 320 304 290.6 1.0 611 603.6
Total 1,028 17,421 2,100 17,747 4,873 1,109 12,050 8,357 64,164 67,018 59,951 131,579

Top of page

Table 3: Notification rates of diseases, 1 April to 30 June 2016, by state or territory. (Annualised rate per 100,000 population)*,†
Disease State or territory Aust.
ACT NSW NT Qld SA Tas. Vic. WA

* The date of diagnosis is the onset date or where the date of onset was not known, the earliest of the specimen collection date, the notification date, or the notification receive date. For hepatitis B (unspecified), hepatitis C (unspecified), leprosy, syphilis (> 2 years or unspecified duration) and tuberculosis, the public health unit notification receive date was used.

† Rate per 100,000 of population. Annualisation Factor was 4.0

‡ Newly acquired hepatitis includes cases where the infection was determined to be acquired within 24 months prior to diagnosis. Queensland reports hepatitis C newly acquired under hepatitis C unspecified.

§ Unspecified hepatitis and syphilis includes cases where the duration of infection could not be determined or is greater than 24 months.

|| Infection with Shiga toxin/verotoxin-producing Escherichia coli.

¶ Includes Chlamydia trachomatis identified from cervical, rectal, urine, urethral and throat samples, except for South Australia, which reports only cervical, urine and urethral specimens.

** The national case definitions for chlamydia, gonococcal and syphilis diagnoses include infections that may be acquired through a non-sexual mode (especially in children – e.g. perinatal infections, epidemic gonococcal conjunctivitis).

†† Only invasive meningococcal disease is nationally notifiable. However, New South Wales and the Australian Capital Territory also report conjunctival cases.

NEC Not elsewhere classified.

NN Not notifiable.
Bloodborne diseases
Hepatitis (NEC) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Hepatitis B (newly acquired)‡ 0.0 0.1 0.0 1.1 0.0 0.0 1.1 1.4 0.7
Hepatitis B (unspecified)§ 22.5 35.0 52.4 23.8 18.4 10.1 36.2 37.7 31.5
Hepatitis C (newly acquired)‡ 4.1 0.2 1.6 0.0 1.9 3.1 1.8 4.5 1.3
Hepatitis C (unspecified)§ 49.1 56.7 99.8 58.8 29.7 40.3 44.7 50.5 51.5
Hepatitis D 0.0 0.2 3.3 0.1 0.5 0.0 0.2 0.0 0.2
Gastrointestinal diseases
Botulism 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Campylobacteriosis 127.9 NN 181.6 136.0 143.1 160.3 118.0 117.2 128.3
Cryptosporidiosis 10.2 16.3 178.3 57.3 24.2 3.9 13.8 11.0 25.2
Haemolytic uraemic syndrome 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0
Hepatitis A 0.0 0.5 0.0 0.3 0.5 0.0 0.4 0.3 0.4
Hepatitis E 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.2 0.1
Listeriosis 0.0 0.6 0.0 0.4 0.0 0.8 0.3 0.2 0.4
Paratyphoid 0.0 0.2 0.0 0.2 0.0 0.8 0.3 0.2 0.2
STEC|| 0.0 0.4 0.0 0.3 7.3 0.0 0.5 0.9 0.9
Salmonellosis 79.8 56.0 400.8 101.2 108.5 58.1 62.5 69.6 75.9
Shigellosis 2.0 4.6 65.4 2.5 2.6 1.5 10.4 3.2 5.9
Typhoid fever 0.0 0.2 0.0 0.5 0.2 0.0 0.4 0.3 0.3
Quarantinable diseases
Avian influenza in humans 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Cholera 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Middle East respiratory syndrome coronavirus 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Plague 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Rabies 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Severe acute respiratory syndrome 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Smallpox 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Viral haemorrhagic fever 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Yellow fever 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Sexually transmitted infections
Chlamydia¶,** 370.3 350.3 1,084.7 484.8 333.8 345.3 77.7 475.1 329.4
Donovanosis 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Gonococcal infection** 39.9 95.4 714.9 78.5 78.2 17.8 117.9 128.8 103.8
Syphilis < 2 years duration** 5.1 9.8 67.1 13.4 4.9 0.8 18.2 10.5 12.7
Syphilis > 2 years or unspecified duration§,** 7.2 4.7 16.4 5.8 6.1 3.9 14.7 2.0 7.4
Syphilis – congenital 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Vaccine preventable diseases
Diphtheria 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0
Haemophilus influenzae type b 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.1
Influenza (laboratory confirmed) 72.6 138.2 85.1 179.0 115.8 56.5 70.1 118.4 122.2
Measles 0.0 0.1 0.0 0.2 0.5 2.3 0.7 0.0 0.3
Mumps 0.0 0.6 29.4 0.9 1.2 0.8 0.3 21.2 3.2
Pertussis 101.3 105.7 88.3 38.7 63.8 7.0 44.0 36.4 63.9
Pneumococcal disease – invasive 7.2 7.7 16.4 6.4 7.8 13.2 7.5 6.0 7.4
Poliovirus infection 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Rubella 0.0 0.3 0.0 0.1 0.0 0.0 0.2 0.0 0.2
Rubella – congenital 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Tetanus 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0
Varicella zoster (chickenpox) 15.3 NN 22.9 7.4 18.6 17.0 15.8 21.2 14.6
Varicella zoster (shingles) 64.4 NN 158.7 1.5 128.8 60.4 35.0 57.1 41.9
Varicella zoster (unspecified) 52.2 NN 4.9 153.6 9.7 27.9 96.3 57.0 93.2
Vectorborne diseases
Barmah Forest virus infection 0.0 0.5 1.6 7.2 0.0 0.0 0.0 0.5 1.7
Chikungunya virus infection 0.0 0.1 1.6 0.1 0.7 0.0 0.3 0.3 0.2
Dengue virus infection 7.2 6.4 62.2 11.3 6.8 11.6 9.4 27.6 11.2
Flavivirus infection (unspecified) 0.0 0.1 1.6 0.8 0.0 0.8 0.1 0.2 0.3
Japanese encephalitis virus infection 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Kunjin virus infection 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Malaria 1.0 0.7 3.3 1.8 0.7 0.0 1.3 1.7 1.2
Murray Valley encephalitis virus infection 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Ross River virus infection 2.0 7.7 68.7 73.9 2.8 1.5 2.6 16.4 20.7
Zoonoses
Anthrax 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Australia bat lyssavirus infection 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Brucellosis 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.1
Leptospirosis 0.0 0.2 0.0 2.7 0.0 0.0 0.0 0.3 0.6
Lyssavirus infection (NEC) 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Ornithosis 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Q fever 1.0 1.9 0.0 4.4 0.7 0.0 0.5 0.6 1.8
Tularaemia 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Other bacterial diseases
Legionellosis 1.0 1.9 0.0 0.9 1.6 3.9 1.1 3.4 1.7
Leprosy 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.1
Meningococcal infection – invasive†† 0.0 0.8 1.6 0.7 1.4 0.0 1.0 0.2 0.8
Tuberculosis 8.2 5.2 14.7 3.5 4.0 1.5 5.8 4.3 4.9

Top of page

In this section

CDI Search

Search Communicable Diseases Intelligence

Communicable Diseases Intelligence subscriptions

Sign-up to email updates: Subscribe Now

Communicable Diseases Surveillance